PharmaIndustrial India Magazine September-October 2023

Macpac Completes Phase Two of GBP 1.5 Million Investment with Installation of Illig Thermoforming Machine SGD Pharma Extends Sterinity Glass Vials for Parenteral Pharmaceutical Applications Macpac has completed the second phase of a GBP 1.5million investment in its 50th anniversary year with the instal- lation of a high speed Illig RDKP 72 au- tomatic pressure thermoforming system at its plant in Stockport. In line with an ambitious growth strate- gy which has been primarily driven by increasing demand from the food and pharmaceutical industries, Macpac’s new Illig six-bar thermoformer is set to offer the company more scope in terms of run speed. It offers industrial process control, forming/punching technology and a maximum forming area of 756mm x 535mm. The advanced machine features a fully robotised stacking system and operates at up to 55 cycles per minute. It facil- itates flexible production of medium to large-sized batch sizes with frequent changes of material type, format and tools. The purchase of this new machine fol- lows the installation of an Illig RD74 down stacking machine with an addi- tional secondary punch press almost 12 months ago. This system has given Macpac the capability to produce ther- moformed packs with holes punched and removed within the forming itself, using its second cut station for the re- quired punching process. The addition of the down stacking station means tooling can be produced more cost-effectively than any upstacked style machine without compromising run speed and quality to the product. Macpac’s Managing Director, Graham Kershaw comments, “The new Illig ther- moformer is another significant invest - ment designed to support further growth both in the UK and overseas markets. In particular, we are now ideally posi- tioned to capture growing demand for our packaging solutions from the global pharmaceutical and food industries. Im- portantly, it will allow us to offer higher volumes while continuing to meet the high standards of service and quality our clients have come to expect. It also reflects utmost confidence in our people and products.” SGD Pharma have released the lat- est expansion of its Sterinity range of Ready-To-Use (RTU) Type I moulded glass vials. The launch of additional siz- es 10H*ml and 20H ml in tray is advanta- geous to customers who will benefit from increased flexibility as a result of the ex - tended portfolio. Demand for high-value parenteral drugs has increased dramatically in recent years, placing more pressure on phar- maceutical companies to accelerate their time tomarket. SGDPharma’s range of RTU Sterinity vials offer customers an efficient solution to the lengthy stages of vial-sterilisation and provides the flexibil - ity they require to prioritise patient safety and distribute medicines significantly faster. Furthermore, by outsourcing the sterilisation process, SGD Pharma’s compliant Sterinity range reduces total cost of ownership (TCO). This latest range extension is the re- sult of customer requests for 10ml and 20ml high-quality sterile vial offerings for aseptic fill/finish of parenteral drugs. The full Sterinity portfolio now includes sizes 10, 20, 50, 100ml ISO and 20, 25, 50 EasyLyo, giving customers access to high-quality solutions from SGD Pharma that have been adapted to suit a wide va- riety of applications and accommodate the needs of many customer markets, including pharmaceutical and biophar- maceutical companies, compounding pharmacies, hospitals and veterinary clinics. Carole Grassi Mircich, Chief Commercial Marketing & Innovation Officer, asserts, “SGD Pharma has a proven record of quickly addressing the evolving phar- maceutical packaging needs of its cus- tomers. Our Sterinity range extension comes at a time when global demand for parenteral drugs is at its peak. Our con- venient new 10ml and 20ml ISO molded glass vials in tray, provide an optimal packaging solution for biologics and innovative treatments that require glass vials for parenteral use. SGD Pharma will continue to innovate and produce high-quality primary glass packaging for our customers and partners, maintaining our position as global industry-leader”. NEWS PHARMA INDUSTRIALINDIA · SEP-OCT 23 10